Fig. 4 | Scientific Reports

Fig. 4

From: Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis

Fig. 4

Receiver operating characteristic curve (A) for determining the cut-off value of TTR10 during the first 4 weeks post-transplantation associated with acute GVHD (Grade II–III) development in PSM episodes. Acute GVHD (Grade II–III) frequency (B) in two groups classified based on the TTR10 cut-off value from PSM episodes. GVHD, graft-versus-host disease; TTR10, time in the therapeutic range at a tacrolimus concentration of ≥ 10 ng/mL; PSM, propensity score matching.

Back to article page